SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-116241
Filing Date
2021-04-14
Accepted
2021-04-14 16:03:03
Documents
12
Period of Report
2021-04-08
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d144585d8k.htm   iXBRL 8-K 22847
  Complete submission text file 0001193125-21-116241.txt   142073

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210408.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210408_lab.xml EX-101.LAB 17306
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210408_pre.xml EX-101.PRE 10945
5 EXTRACTED XBRL INSTANCE DOCUMENT d144585d8k_htm.xml XML 3342
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 21825725
SIC: 2836 Biological Products, (No Diagnostic Substances)